Sequentify

Sequentify

Biotechnology

Make targeted sequencing as common and affordable as a blood test.

About us

At Sequentify, we empower genomic labs to achieve scalable, population-wide genomic sequencing through our innovative solutions. Our technology is designed to decentralize genomic testing by addressing the industry's top three challenges: sample preparation, result analysis, and cost reduction. Our end-to-end solution offers unmatched scalability, automation friendliness, and cost-effectiveness, making it ideal for diverse applications, including cancer diagnostics, carrier screening, and infectious disease. Currently raising our Series A round, as we aim to accelerate growth.

Industry
Biotechnology
Company size
11-50 employees
Headquarters
Rehovot
Type
Privately Held
Founded
2021
Specialties
Genomics, Next Generation Sequencing, Diagnoistcs, and Personalized Medicine

Locations

Employees at Sequentify

Updates

Similar pages

Funding

Sequentify 3 total rounds

Last Round

Grant

US$ 1.3M

See more info on crunchbase